These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10224989)

  • 1. Weekly patterns of drug treatment attendance.
    Svikis DS; Pickens RW; Schweitzer W; Johnson E; Haug N
    Am J Public Health; 1999 May; 89(5):752-5. PubMed ID: 10224989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External pressure, motivation, and treatment outcome among pregnant substance-using women.
    Ondersma SJ; Winhusen T; Lewis DF
    Drug Alcohol Depend; 2010 Mar; 107(2-3):149-53. PubMed ID: 19926408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with lifetime history of drug treatment among substance dependent women.
    Walton-Moss B; McCaul ME
    Addict Behav; 2006 Feb; 31(2):246-53. PubMed ID: 15979246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women in residential drug treatment: differences by program type and pregnancy.
    Grella CE
    J Health Care Poor Underserved; 1999 May; 10(2):216-29. PubMed ID: 10224827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing retention of African-American women on welfare in outpatient substance user treatment using low-magnitude incentives.
    Bride BE; Humble MN
    Subst Use Misuse; 2008 Jul; 43(8-9):1016-26. PubMed ID: 18649227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of substance abuse during pregnancy.
    Lester BM; Twomey JE
    Womens Health (Lond); 2008 Jan; 4():67-77. PubMed ID: 19072452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.
    Terplan M; Lui S
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006037. PubMed ID: 17943878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Early Substance Use Disorder Treatment Response on Treatment Outcomes Among Pregnant Women With Primary Opioid Use.
    Tuten M; Fitzsimons H; Hochheimer M; Jones HE; Chisolm MS
    J Addict Med; 2018; 12(4):300-307. PubMed ID: 29538089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program.
    Green CA; Polen MR; Dickinson DM; Lynch FL; Bennett MD
    J Subst Abuse Treat; 2002 Dec; 23(4):285-95. PubMed ID: 12495790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Welfare receipt and substance-abuse treatment among low-income mothers: the impact of welfare reform.
    Pollack HA; Reuter P
    Am J Public Health; 2006 Nov; 96(11):2024-31. PubMed ID: 17018836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing treatment enrollment by pregnant substance abusers.
    Haller DL; Miles DR; Dawson KS
    Am J Drug Alcohol Abuse; 2003; 29(1):117-31. PubMed ID: 12731684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "A Résumé for the Baby": Biosocial Precarity and Care of Substance-Using, Pregnant Women in San Francisco.
    Premkumar A; Kerns J; Huchko MJ
    Cult Med Psychiatry; 2020 Mar; 44(1):35-55. PubMed ID: 31055757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family discord is associated with increased substance use for pregnant substance users.
    Denton WH; Adinoff BH; Lewis D; Walker R; Winhusen T
    Subst Use Misuse; 2014 Feb; 49(3):326-32. PubMed ID: 24106976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnant and non-pregnant women with substance use disorders: the gap between treatment need and receipt.
    Terplan M; McNamara EJ; Chisolm MS
    J Addict Dis; 2012; 31(4):342-9. PubMed ID: 23244553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of substance abuse treatment services by persons with mental health and substance use problems.
    Wu LT; Ringwalt CL; Williams CE
    Psychiatr Serv; 2003 Mar; 54(3):363-9. PubMed ID: 12610245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Where do they fit? Specialized services for pregnant women who are drug addicted.
    Siney C
    Pract Midwife; 1998 Oct; 1(10):12-4. PubMed ID: 10026577
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing the recognition of barriers for pregnant substance users seeking treatment.
    Shannon L; Walker R
    Subst Use Misuse; 2008 Jul; 43(8-9):1266-7. PubMed ID: 18649244
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of motivational enhancement therapy to decrease alcohol and illicit-drug use in pregnant substance users reporting baseline alcohol use.
    Osterman R; Lewis D; Winhusen T
    J Subst Abuse Treat; 2017 Jun; 77():150-155. PubMed ID: 28254158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic and psychosocial characteristics of substance-abusing pregnant women.
    Hans SL
    Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women-Centered Drug Treatment Services and Need in the United States, 2002-2009.
    Terplan M; Longinaker N; Appel L
    Am J Public Health; 2015 Nov; 105(11):e50-4. PubMed ID: 26378825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.